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We have studied the differences between erythrocytes and erythrocyte ghosts as target mem-
branes for the study of Sendai virus fusion activity. Fusion was monitored continuously by
fluorescence dequenching of R18-labeled virus. Experiments were carried out either with or
without virus/target membrane prebinding. When Sendai virus was added directly to a
erythrocyte/erythrocyte ghost suspension, fusion was always lower than that obtained when
experiments were carried out with virus already bound to the erythrocyte/erythrocyte ghost
in the cold, since with virus prebinding fusion can be triggered more rapidly. Although
virus binding to both erythrocytes and erythrocyte ghosts was similar, fusion activity was
much more pronounced when erythrocyte ghosts were used as target membranes. These
observations indicate that intact erythrocytes and erythrocyte ghosts are not equivalent as
target membranes for the study of Sendai virus fusion activity. Fusion of Sendai virus with
both target membranes was inhibited when erythrocytes or erythrocyte ghosts were pre-
treated with proteinase K, suggesting a role of target membrane proteins in this process.
Treatment of both target membranes with neuraminidase, which removes sialic acid resi-
dues (the biological receptors for Sendai virus) greatly reduced viral binding. Interestingly,
this treatment had no significant effect on the fusion reaction itself.
KEY WORDS: Sendai virus; erythrocytes; erythrocyte ghosts; membrane fusion;
fluorescence dequenching.
ABBREVIATIONS: EGTA, Ethylene glycol-bis(b-aminoethyl ether)N,N,N',N'-tetraacetic
acid; R18-octadecylrhodamine B chloride.
INTRODUCTION
Sendai virus (hemagglutinating virus of Japan) belongs to the paramyoxovirus fam-
ily, and like many other enveloped viruses, infects host cells by a membrane fusion
event (Hoekstra and Kok, 1989; Hoekstra, 1990; Stegmann et al., 1989). Fusion
takes place at neutral pH and is mediated by two viral membrane glycoproteins, one
involved in virus-cell binding and one specific for fusion (Haywood and Boyer, 1982;
Hoekstra et al., 1985). The protein designated HN has hemagglutinating and neur-
aminidase activities and mediates the initial virus-target membrane binding, while
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the fusion protein (F) triggers the actual membrane merging (Novick and Hoekstra,
1988).
Although Sendai virus infects living cells, erythrocyte ghosts have been fre-
quently used as target membranes in studies of viral fusion activity (Hoekstra et al.,
1985; Hoekstra and Klappe, 1986; Stegmann et al., 1986). However, during the
preparation of the erythrocyte ghosts several factors can modify membrane physical
properties and alter the structure of membrane surface components (Schwoch and
Passow, 1973) that may be involved in the fusion process. Therefore we have investi-
gated the differences between human erythrocyte ghosts and human erythrocytes as
target membranes for the study of Sendai virus fusion activity. Fusion of Sendai
virus with both target membranes was monitored with the R18-fluorescence assay,
which allows a sensitive and continuous monitoring of fusion between native biologi-
cal membranes (Hoekstra et al., 1984; Pedroso de Lima et al., 1995).
We have also investigated the potential role of membrane proteins in the fusion
process. For this purpose erythrocytes and erythrocyte ghosts were pretreated with
proteinase K, and Sendai virus fusion activity towards both treated target mem-
branes was examined. Sialic acid residues have been recognized as membrane recep-
tors for binding of both Sendai and influenza viruses (Haywood and Boyer, 1982;
Hoekstra, 1990), and have also been shown to modulate influenza virus fusion
activity (Stegmann et al., 1986). We were interested in studying the role of these
residues in Sendai virus fusion activity using our experimental system. Therefore,
erythrocytes and erythrocyte ghosts were treated with neuraminidase and the effect
of this pretreatment on virus-target membrane binding and on the fusion process
itself was assessed.
MATERIALS AND METHODS
Chemicals
Octadecylrhodamine B chloride (R18) was obtained from Molecular Probes
Inc. (Eugene, OR), neuraminidase was purchased from Calbiochem (San Diego, CA)
and proteinase K was obtained from Sigma Chemical Co. (St. Louis, MO).
Virus
Sendai virus (Hemagglutinating virus of Japan), Z strain, was obtained from
SPAFAS Inc. (Preston, CT). The virus was grown for 72 h in the allantoic cavity of
10-day-old embryonated eggs, purified by differential centrifugation and stored at
–70°C in phosphate buffered saline (Maeda et al., 1975).
Virus Labeling
Sendai virus was labeled with Octadecylrhodamine B chloride as described pre-
viously (Hoekstra et al., 1984; Ramalho-Santos et al., 1993). The final concentration
of added probe corresponded to approximately 5 mole % of total viral lipid and that
of ethanol was less than 1% (v/v). The mixture was incubated in the dark for 30 min
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at room temperature. R18-labeled virus was separated from non inserted fluoro-
phore by chromatography on Sephadex G-75 (Pharmacia, Uppsala, Sweden) using
10 mM HEPES, 150 mM NaCl, pH 7.4 as elution buffer. The protein concentration
of the labeled virus was determined by the Lowry assay.
Preparation of Erythrocytes and Erythrocyte Ghosts
Erythrocytes were obtained from freshly drawn human blood by centrifugation
at 2300g in a Sorvall centrifuge using the SS-34 rotor for 10 min at 4°C. The erythro-
cyte pellet was washed three times with 5 mM sodium phosphate, 150 mM NaCl,
0.1% BSA, pH 7.4. The erythrocytes were counted in a hemocytometer and stored
at 4°C.
Erythrocyte ghosts were prepared from freshly drawn human blood by hypo-
tonic lysis of the erythrocytes in 5 mM sodium phosphate, 0.1 mM EGTA, pH 8.0
at 4°C, essentially as described by Steck and Kant (Steck and Kant, 1974). The
erythrocyte ghosts were counted in a hemocytometer and stored at 4°C.
Enzymatic Treatment
For proteinase K treatment 2 × 108 of erythrocytes/erythrocyte ghosts were
incubated for 30 min at 37°C with 700 ug of proteinase K in 1 ml of 5 mM sodium
phosphate, 150 mM NaCl, pH 7.4. Following this incubation, the target membranes
were centrifuged at 22,000g in a Sorvall centrifuge using the SE-12 rotor for 10 min
at 4°C. The pellet was resuspended in 2 ml of 10 mM HEPES, 150 mM NaCl, pH 7.4
and washed three more times. Neuraminidase treatment of erythrocytes/erythrocyte
ghosts was carried out with 10 milliunits of Clostridium perfringens neuraminidase/
2 × 108 of erythrocytes/erythrocyte ghosts in 0.5 ml of 50 mM sodium acetate,
154 mM NaCl, 4 mM CaCl2, pH 5.5 for 60 min at 37°C. Following this incubation,
the target membranes were centrifuged at 22,000g in a Sorvall centrifuge using the
SE-12 rotor for 10 min at 4°C. The pellet was resuspended in 2 ml of 10 mM HEPES,
150 mM NaCl, pH 7.4 and washed three more times.
Fusion of R18-Labeled Sendai Virus with Erythrocytes or Erythrocyte Ghosts
Fusion was monitored using a procedure that detects the merging of lipid bilay-
ers. The method relies upon the relief of fluorescence self-quenching of R18. Upon
fusion of R18-labeled virus with target membranes devoid of the probe, the surface
density of R18 will decrease as a result of mixing the viral and target membrane
components, allowing an accurate measurement of the fusion reaction (Hoekstra et
al., 1984; Pedroso de Lima et al., 1992).
We used two different experimental approaches to monitor membrane merging.
In one of the procedures fusion was initiated by rapid injection of R18-labeled virus
into a cuvette containing the erythrocytes or erythrocyte ghosts suspension, and
fusion monitored continuously as a function of R18 dequenching. In the other exper-
imental procedure the virus was added to the target membranes on ice in a small
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volume of buffer and incubated for 15 min. Fusion was monitored after the virus-
target membrane mixture was transferred to prewarmed buffer at 37°C in the
fluorometer cuvette. Fusion experiments were always carried out with 2 × 108
of erythrocytes/erythrocyte ghosts and 10 ug of Sendai virus in a final incubation
volume of 2 ml.
Fluorescence measurements were performed in a Spex Fluorolog fluorometer
with excitation at 560 nm and emission at 590 nm, using the front-face configuration
in the emission channel and a filter at the emission monochromator, in order to
reduce the contribution of light scattering. The sample chamber was equipped with
a magnetic stirring device, and the temperature was controlled with a thermostatted
circulating water bath. The fluorescence scale was calibrated such that the initial
fluorescence of R18-labeled virus and erythrocytes or erythrocyte ghosts was set at
0% fluorescence. The value obtained after solubilization of the virus and the target
membranes at the end of each experiment with 1% (v/v) Triton X-100, was set at
100% fluorescence.
Measurement of Sendai Virus–Erythrocytes/Erythrocyte Ghosts Binding
R18-labeled Sendai virus (5 ug/ml) and erythrocytes/erythrocyte ghosts
(1 × 108/ml), were incubated in a final volume of 2 ml of 10 mM HEPES, 150 mM
NaCl, pH 7.4, on ice, for 30 min. Under these conditions fusion between Sendai
virus and erythrocytes/erythrocyte ghosts is inhibited, although the aggregation pro-
cess takes place. The samples were then centrifuged at 10,500g for 8 min. Upon
centrifugation target membranes pellet, while unbound virions remain in the super-
natant. Binding percentages were calculated from fluorescence values after addition
of 1% (v/v) Triton X-100, both for the supernatant and the pellet (resuspended in
2 ml of buffer). Fluorescence measurements were performed as previously described.
RESULTS AND DISCUSSION
Erythrocyte and Erythrocyte Ghosts as Target Membranes for the Study of
Sendai Virus Fusion Activity
Many studies concerning the fusion activity of lipid-enveloped viruses use
erythrocyte ghosts as target membranes for these pathogenic agents. However during
the preparation of the erythrocyte ghosts several factors can modify the structure of
membrane surface. Therefore, we have tried to investigate the differences between
human erythrocytes and human erythrocyte ghosts as target membranes for Sendai
virus, using the R18 fluorescence dequenching assay, a reliable indicator of virus-
cell fusion in numerous systems (Duzgunes et al., 1992; Gilbert et al., 1990:
Hoekstra, 1990; Pedroso de Lima et al., 1991; Puri et al., 1993; Ramalho-Santos et
al., 1993).
The fusion activity of R18-labeled Sendai virus towards erythrocytes/erythro-
cyte ghosts is shown in Fig. 1. Two different experimental approaches were used to
quantify viral fusion activity. In one set of experiments the virus was allowed to
bind to erythrocytes/erythrocyte ghosts for 15 min on ice before initiation of the
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Fig. 1. Sendai virus fusion activity towards erythrocytes and erythrocyte ghosts.
Sendai virus (5 ug viral protein/ml) was added to 1 × 108 erythrocyte ghosts (open
bars) or erythrocytes (striped bars) in a final volume of 2 ml at 37°C. The extent of
R18 fluorescence dequenching was measured after 10 min incubation at pH 7.4, with
or without prebinding of the virus to the cells. In the case of viral prebinding, the
virus was pre-incubated with erythrocytes/erythrocyte ghosts for 15 min at neutral
pH on ice. In the absence of viral prebinding, fusion was initiated by rapid injection
of the virus to the erythrocytes/erythrocyte ghosts suspension. Values represent
means of 5 experiments ± standard deviation. ++P<0.01; +++P<0.001, signifi-
cantly different compared to no prebinding conditions. ***P< 0.001, significantly
different compared to ghosts under the same conditions.
fusion reaction at neutral pH (experiments with virus-target membrane prebinding).
In the other set of experiments, fusion was initiated by rapid injection of the virus
to the erythrocytes/erythrocyte ghosts (experiments without virus-target membrane
prebinding). When the virions were prebound to the target membranes the extent of
fusion was higher (Fig. 1), as would be expected, since with virus prebinding on ice,
fusion can be triggered more rapidly. On the other hand, when virions are added
directly to target membranes, they must bind to erythrocytes or erythrocyte ghosts
before membrane merging can take place. However, since this process corresponds
to the biological fusion reaction, further experiments were carried out without viral
prebinding to target membranes.
Resealed erythrocyte membranes (ghosts) are valuable tools in the study of
biological membrane functions, since after hypotonic lysis and subsequent resealing,
the membrane regains many of its natural characteristics (Lieber and Steck, 1982a;
1982b; Wood and Passow, 1981). However, Sendai virus does not exhibit the same
fusion behavior towards erythrocytes and erythrocyte ghosts. Indeed, Sendai virus
fuses much more extensively with erythrocyte ghosts than with erythrocytes (Fig. 1).
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This difference is probably related to differences in the membrane packing of both
targets. During the preparation of erythrocyte ghosts, in the step of hypotonic hemo-
lysis, a single large fenestration is opened in the membrane by the imposed osmotic
stress (Lieber and Steck, 1982a; 1982b). The hole is a breach in membrane conti-
nuity normally ascribed to the bilayer, to the membrane proteins and, in particular,
to the reticulum of spectrin and actin that covers the cytoplasmatic surface (Lieber
and Steck, 1982b). The changes that occur in the erythrocyte membrane during ghost
formation may not be completely reversed by the resealing procedure, thus affecting
bilayer packing. Our supposition is in agreement with other studies where it was
observed that the acyl chain mobility of the outer leaflet of ghost membranes is
higher than that of erythrocytes (Herrmann et al., 1993). Increased acyl chain
mobility of membrane phospholipids and hydrophobicity of the membrane surface
may facilitate the process of membrane fusion.
These results indicate that extrapolation of the characteristics of viral fusion
activity towards erythrocyte ghosts should be made with caution. Membrane organ-
ization and dynamics or some membrane component appear to be significant factors
in Sendai virus-induced fusion. Interestingly Sendai virus binding was virtually the
same towards both erythrocytes/erythrocyte ghosts (Table I), suggesting that mem-
brane surface characteristics (at least in what concerns sialic acid residues) is not
affected by the preparation of erythrocyte ghosts.
Effect of Proteinase K Pretreatment of Erythrocytes and Erythrocyte Ghosts on
Sendai Virus Fusion Activity
In order to determine whether the differences between erythrocyte ghosts and
erythrocytes as targets for Sendai virus concerned surface proteins, both target mem-
branes were treated with proteinase K. This proteolytic treatment did not promote
significant differences in the binding capacity of Sendai virus towards erythrocyte
ghosts and erythrocytes (data not shown). However, inhibition of the fusion process
of Sendai virus with both target membranes was observed (Fig. 2).
These results indicate the existence of membrane components cleaved by pro-
teinase K, which may facilitate the formation of a fusogenic complex between the
virus and the target membrane. It is possible that the proteins cleaved by proteinase
Table 1. Binding of Sendai Virus to Erythrocytes and
Erythrocyte Ghosts
Binding (%)
Cells
Binding (%)
Ghosts
60.72 ± 2.08
Erythrocytes
59.41 ±0.38
Sendai virus (5 ug viral protein/ml) was added to 1 × 108
erythrocytes/erythrocyte ghosts in a final volume of 2 ml at
0°C and pH 7.4. Following a 30 min incubation, the mixture
was centrifuged and virus-target membrane binding was
quantified after triton X-100 addiction, to both pellet and
supernatant, as described in Materials and Methods. Values
represent means of 2-5 experiments ± standard deviation.
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Fig. 2. Effect of Proteinase K pretreatment of erythrocytes and erythrocyte ghosts
on Sendai virus fusion activity. Sendai virus (5ug viral protein/ml) was added to
1 × 108 control (striped bars) or proteinase K treated (threaded bars) erythrocyte
ghosts/erythrocytes in a final volume of 2 ml at 37°C. The extent of R18 fluor-
escence dequenching was measured after 10 min incubation at pH 7.4, with viral
prebinding to the target cells. In prebinding, the virus was pre-incubated with
erythrocytes/erythrocyte ghosts for 15 min at neutral pH on ice. Values represent
means of 2-5 experiments ± standard deviation. *P<0.05; **P<0.01, signifi-
cantly different compared to control conditions.
K are involved in the establishment of a correct positioning of the virus after binding
and before fusion.
Effect of Neuraminidase Pretreatment of Erythrocytes and Erythrocyte Ghosts on
Sendai Virus Fusion Activity
The initial event in the entry of a lipid-enveloped virus into host cells is viral
attachment to specific receptors. Sialic acid residues present on membrane glyco-
proteins or glycolipids at the cell surface have been considered to be the primary
receptors for Sendai (Markwell et al., 1984; White, 1990) and influenza viruses
(Bengelson et al., 1982; Pedroso de Lima et al., 1995; Paulson et al., 1986). The
presence of these residues has also been shown to modulate influenza virus fusion
activity (Pedroso de Lima et al., 1991).
However, in contrast to what has been obtained with influenza virus (Stegmann
et al., 1986), and that we have confirmed (data not shown), we have not observed
any significant effect of neuraminidase pretreatment of target membranes on Sendai
virus fusion with both erythrocytes and erythrocyte ghosts (Fig. 3). Interestingly,
virus-target membrane binding towards both types of target membranes was signifi-
cantly reduced following pretreatment with neuraminidase (Table II). These results
confirm the importance of sialic acid residues as viral receptors for Sendai virus.
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Fig. 3. Effect of neuraminidase pretreatment of erythrocytes and erythrocyte ghosts
on Sendai virus fusion activity. Sendai virus (5 ug viral protein/ml) was added to
1 × 108 control (striped bars) or neuraminidase-treated (threaded bars) erythrocyte
ghosts/erythrocytes in a final volume of 2 ml at 37°C. The extent of R18 fluorescence
dequenching was measured after 10 min incubation at pH 7.4, without prebinding
of the virus to the cells. Fusion was initiated by rapid injection of the virus to the
cell/ghost suspension. Values represent means of 2-5 experiments ± standard
deviation.
However, under our experimental conditions a decrease in viral binding does not
affect the extent of the fusion reaction itself. It should be noted that recent studies
have shown that binding of Sendai virus is more sensitive than fusion to the pres-
ence/absence of sialic acid residues on target membranes (Wybenga et al., 1996).
It is possible that the neuraminidase pretreatment affects target membranes in
a way which facilitates membrane merging. In fact, Yamaguchi et al. (1993) observed
that erythrocyte membranes in which sialic acid had been removed by neuraminidase
become more fragile with respect to their susceptibility to undergo hemolysis under
osmotic stress as compared to intact cells. Sialic acid residues may, as well, play a
barrier between the virus and the target membrane, and thus the removal of these
residues may facilitate membrane fusion. These effects could compensate for the
lower binding of Sendai virus towards both types of target membranes.
In conclusion, our results clearly show that erythrocytes and erythrocyte ghosts
are not equivalent as target membranes for the study of Sendai virus fusion activity,
probably due to differences in bilayer packing. Although target membrane proteins
may play a role in Sendai virus-induced membrane fusion, it seems clear that target
membrane sialic acid residues (the biological receptors for the virus) do not have a
significant effect in directly modulating membrane merging, in sharp contrast to
what happens with the fusion event promoted by influenza virus.
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Table 2. Effect of Neuraminidase Pretreatment on Sendai
Virus Binding Towards Erythrocytes and Erythrocyte
Ghosts
Binding (% control)
Cells Ghosts Erythrocytes
NA-treated 43.89 ± 3.35** 29.33 ± 0.65**
Sendai virus (5 ug viral protein/ml) was added to 1 × 108
control or neuraminidase-treated erythrocytes/erythrocyte
ghosts in a final volume of 2 ml at 0°C and pH 7.4. Follow-
ing a 30 min incubation, the mixture was centrifuged and
virus-target membrane binding was quantified after triton
X-100 addition, to both pellet and supernatant, as described
in Materials and Methods. Values represent means of 2-5
experiments ± standard deviation **P<0.01; ***P< 0.001,
significantly different compared to control conditions.
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